Bioavailability of epinephrine from Auvi-Q compared with EpiPen

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 2, 2013, Pages 132-137

  Edwards, Eric S ^a   Gunn, Ronald ^a   Simons, Estelle R ^b   Carr, Kathy ^c   Chinchilli, Vernon M ^d   Painter, Gwendolyn ^e   Goldwater, Ronald ^f  

^a Intelliject Inc   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c RRD International   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e PAREXEL INTERNATIONAL   (United States)

^f Independent Consulting Physician   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN;

ADULT; ADVERSE OUTCOME; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG EXPOSURE; DRUG SAFETY; EPINEPHRINE AUTOINJECTOR; FEMALE; HUMAN; HUMAN EXPERIMENT; INJECTION SITE BLEEDING; INJECTION SITE PAIN; MALE; MAXIMUM PLASMA CONCENTRATION; MEDICAL DEVICE; MEDICAL ERROR; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF INJECTION; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE;

ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; EPINEPHRINE; FEMALE; HUMANS; MALE; ROC CURVE; SELF ADMINISTRATION; SINGLE-BLIND METHOD;

EID: 84880814658     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.06.002     Document Type: Article

References (34)

1. H.A. Sampson, A. Muñoz-Furlong, and R.L. Campbell Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium J Allergy Clin Immunol 117 2006 391 397 (Pubitemid 43190153)
2. P. Lieberman, R.A. Nicklas, and J. Oppenheimer The diagnosis and management of anaphylaxis practice parameter: 2010 update J Allergy Clin Immunol 126 2010 477 480
3. F.E. Simons, L.R. Ardusso, and M.B. Bilò World Allergy Organization anaphylaxis guidelines: summary J Allergy Clin Immunol 127 2011 587 593.e1-22
4. F.E. Simons Anaphylaxis: evidence-based long-term risk reduction in the community Immunol Allergy Clin North Am 27 2007 231 248 vi-vii (Pubitemid 46711076)
5. A. Mehl, U. Wahn, and B. Niggemann Anaphylactic reactions in children: a questionnaire-based survey in Germany Allergy 60 2005 1440 1445 (Pubitemid 41476190)
6. S.H. Sicherer, A. Forman, and S.A. Noone Use assessment of self-administered epinephrine among food-allergic children and pediatricians Pediatrics 105 2000 359 362 (Pubitemid 30078678)
7. L.M. Webb, and P. Lieberman Anaphylaxis: a review of 601 cases Ann Allergy Asthma Immunol 97 2006 39 43 (Pubitemid 44156335)
8. F.E. Simons, S. Clark, and C.A. Camargo Jr. Anaphylaxis in the community: learning from the survivors J Allergy Clin Immunol 124 2009 301 306
9. M. Grouhi, M. Alshehri, D. Hummel, and C.M. Roifman Anaphylaxis and epinephrine auto-injector training: who will teach the teachers? J Allergy Clin Immunol 104 1999 190 193 (Pubitemid 29364503)
10. S. Mehr, M. Robinson, and M. Tang Doctor-how do I use my EpiPen? Pediatr Allergy Immunol 18 2007 448 452
11. F.E. Simons, P.L. Lieberman, E.J. Read Jr., and E.S. Edwards Hazards of unintentional injection of epinephrine from autoinjectors: a systematic review Ann Allergy Asthma Immunol 102 2009 282 287
12. F.E. Simons, E.S. Edwards, E.J. Read, S. Clark, and E.L. Liebelt Voluntarily reported unintentional injections from epinephrine auto-injectors J Allergy Clin Immunol 125 2010 419 423.e4
13. K.J. Simons, and F.E. Simons Epinephrine and its use in anaphylaxis: current issues Curr Opin Allergy Clin Immunol 10 2010 354 361
14. S. Guerlain, A. Hugine, and L. Wang A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference Ann Allergy Asthma Immunol 104 2010 172 177
15. S. Guerlain, L. Wang, and A. Hugine Intelliject's novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with EpiPen and Twinject Ann Allergy Asthma Immunol 105 2010 480 484
16. C.A. Camargo, A. Guana, S. Wang, and F.E.R. Simons Auvi-Q Versus EpiPen: preferences of adults, caregivers, and children J Allergy Clin Immunol Pract 1 2013 266 272.e3
17. F.E. Simons, J.R. Roberts, X. Gu, and K.J. Simons Epinephrine absorption in children with a history of anaphylaxis J Allergy Clin Immunol 101 1998 33 37 (Pubitemid 28112878)
18. F.E. Simons, X. Gu, and K.J. Simons Epinephrine absorption in adults: intramuscular versus subcutaneous injection J Allergy Clin Immunol 108 2001 871 873 (Pubitemid 33096224)
19. S.H. Haidar, F. Makhlouf, and D.J. Schuirmann Evaluation of a scaling approach for the bioequivalence of highly variable drugs AAPS J 10 2008 450 454
20. T. Hyslop, F. Hsuan, and D.J. Holder A small sample confidence interval approach to assess individual bioequivalence Stat Med 19 2000 2885 2897
21. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. 2001. http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070244.pdf. Accessed March 19, 2013.
22. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations. 2003. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070124.pdf. Accessed March 19, 2013.
23. V.M. Chinchilli, and J.D. Esinhart Design and analysis of intra-subject variability in cross-over experiments Stat Med 15 1996 1619 1634 (Pubitemid 26261586)
24. McNally RJ. Tests for Individual and Population Bioequivalence Using 3-period Crossover Designs. Fort Collins: Department of Statistics, Colorado State University; 2002. http://www.stat.colostate.edu/statresearch/ stattechreports/Technical%20Reports/2002/02-7%20McNally.pdf. Accessed September 19, 2011.
25. A.J. Frew What are the 'ideal' features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis? Allergy 66 2011 15 24
26. E.S. Edwards, E.T. Edwards, R. Gunn, P. Patterson, and R. North Design validation and labeling comprehension study for a new epinephrine autoinjector Ann Allergy Asthma Immunol 110 2013 189 193.e1
27. Food and Drug Administration. Center for Drug Evaluation and Research. Application Number: 201739Orig1s000. Clinical Pharmacology and Biopharmaceutics Review(s). http://www.accessdata.fda.gov/drugsatfda-docs/nda/2012/ 201739Orig1s000ClinPharmR.pdf. Accessed April 11, 2013.
28. Dey Pharma LP. Prescribing information. EpiPen (epinephrine) and EpiPen Jr (epinephrine) Auto-Injectors. http://files.epipen.gethifi.com/footerpdfs/ patient-packaging-insert-pdf/Prescribing-Information.pdf. Accessed January 7, 2013.
29. F.E. Simons, X. Gu, N.A. Silver, and K.J. Simons EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis J Allergy Clin Immunol 109 2002 171 175 (Pubitemid 34112148)
30. A.P. McLean-Tooke, C.A. Bethune, A.C. Fay, and G.P. Spickett Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 327 2003 1332 1335 (Pubitemid 37510459)
31. M. Triggiani, V. Patella, R.I. Staiano, F. Granata, and G. Marone Allergy and the cardiovascular system Clin Exp Immunol 153 suppl 1 2008 S7 S11
32. U.R. Mueller Cardiovascular disease and anaphylaxis Curr Opin Allergy Clin Immunol 7 2007 337 341 (Pubitemid 47052022)
33. M. Ridella, S. Bagdure, K. Nugent, and C. Cevik Kounis syndrome following beta-lactam antibiotic use: review of literature Inflamm Allergy Drug Targets 8 2009 11 16
34. M. Biteker, N.E. Duran, and F.S. Biteker Allergic myocardial infarction in childhood: Kounis syndrome Eur J Pediatr 169 2010 27 29